Recent Research | Page 18 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journal Bone Marrow Disease
Paroxysmal nocturnal hemoglobinuria with different presentations : A review of three cases Oct 2016 J Assoc Physicians India paroxysmal nocturnal hemoglobinuria (PNH)
Pathogenesis of paroxysmal nocturnal hemoglobinuria Oct 2016 Rinsho Ketsueki
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes Oct 2016 Rev Assoc Med Bras myelodysplastic syndromes (MDS)
Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki Oct 2016 Cancer Sci. myelodysplastic syndromes (MDS)
Positive Impact of Eculizumab Therapy on Surgery for Budd-Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Long-Term History of Thrombosis Sep 2016 Hematol Rep paroxysmal nocturnal hemoglobinuria (PNH)
Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related? Sep 2016 Br J Haematol myelodysplastic syndromes (MDS)
A plasma microRNA signature as a biomarker for acquired aplastic anemia Sep 2016 Haematologica aplastic anemia
Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes Sep 2016 Haematologica myelodysplastic syndromes (MDS)
Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes Sep 2016 2016 Sep 21 myelodysplastic syndromes (MDS)
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT Sep 2016 Ann Hematol myelodysplastic syndromes (MDS)